Ng, J.S., Wong, W., Law, R.W., Hui, J., Wong, E.N. and Lam, D.S. (2001) Ocular Complications of Pediatric Patients with Nephrotic Syndrome. Clinical & Experimental Ophthalmology, 29, 239-243. https://doi.org/10.1046/j.1442-9071.2001.00426.x

has been cited by the following article:

• TITLE: Is the Treatment of Attention Deficit Hyperactivity Disorder a New Cause of Cataract?

  AUTHORS: Mujdat Karabulut, Sinem Karabulut, Tolga Kocatürk, Seyhan Bahar Ozkan

  KEYWORDS: Attention Deficit Hyperactivity Disorder, Methylphenidate, Cataract

  JOURNAL NAME: Open Journal of Ophthalmology, Vol.8 No.1, February 5, 2018

  ABSTRACT: Attention deficit hyperactivity disorder (ADHD) is the most common behavioral disorder of childhood and it has 5% prevalence among children worldwide [1]. In the treatment of ADHD stimulant medications are recommended as the first choice of pharmacotherapy [2]. Methylphenidate-HCl is a sympathomimetic amine derivative pharmacological agent; and it is widely used in the treatment of ADHD. Although there are some articles showing that oral methylphenidate increases the risk of glaucoma [3], to the best of our knowledge, there is only one case report that indicates a possible relation of methylphenidate treatment and cataract formation [4].